Kleema Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.14 M
- Company Age 38 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.60 M
- Revenue Growth -76.96%
- Profit Growth -120.94%
- Ebitda -118.72%
- Net Worth -5.71%
- Total Assets -69.70%
About Kleema Chemicals
Kleema Chemicals Pvt Ltd (KCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 September 1986 and has a history of 38 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.14 M.
The company has closed loans amounting to ₹1.60 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Avinash Agarwal and Ajay Agarwal serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U99999MH1986PTC040993
-
Company No.
040993
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Sep 1986
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kleema Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avinash Agarwal
|
Director | 30-Mar-2009 | Current |
|
Ajay Agarwal
|
Director | 22-Sep-1986 | Current |
Financial Performance of Kleema Chemicals.
Kleema Chemicals Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 76.96% decrease. The company also saw a substantial fall in profitability, with a 120.94% decrease in profit. The company's net worth dipped by a decrease of 5.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kleema Chemicals?
Unlock access to Kleema Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0
₹1.60 M
Charges Breakdown by Lending Institutions
- Dombivli Nagari Sahakari Bank Ltd : 0.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2003 | Dombivli Nagari Sahakari Bank Ltd | ₹1.60 M | Satisfied |
How Many Employees Work at Kleema Chemicals?
Unlock and access historical data on people associated with Kleema Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kleema Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kleema Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
